Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Neuroimmunology|November 21, 2017
Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapsesSimona Rolla, Stefania Federica De Mercanti, Valentina Bardina, et al.
Journal of Neurology|October 1, 2008
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal respondersLuca Durelli, Pierangelo Barbero, Mauro Bergui, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2012
Th17 cells in multiple sclerosis express higher levels of JAK2, which increases their surface expression of IFN-γR2Laura Conti, Raffaele De Palma, Simona Rolla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2016
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 monthsStefania De Mercanti, Simona Rolla, Angele Cucci, et al.
Annals of Neurology|June 5, 2003
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1aFrederik Barkhof, Mara Rocca, Gordon Francis, et al.
Annals of Neurology|August 28, 2014
Epigenetic therapy for Friedreich ataxiaElisabetta Soragni, Wenyan Miao, Marco Iudicello, et al.
Frontiers in Immunology|January 24, 2019
Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple SclerosisAndrea Iannello, Simona Rolla, Alessandro Maglione, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2019
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MSCaroline Lavie, Fabien Rollot, Françoise Durand-Dubief, et al.
Pageof 4